INTERESTED IN THIS RESEARCH?
Contact our analysts for inquiries, samples, and expert insights.
Report Outlook
| Market Size | CAGR | Dominating Region |
|---|---|---|
| USD 13.6 billion by 2029 | 6.8% | North America |
| By Therapeutic Area | By Route of Administration | By Sterility |
|---|---|---|
|
|
|
SCOPE OF THE REPORT
Compounding Pharmacies Market Overview
The global compounding pharmacies market is expected to grow at 6.8 % CAGR from 2020 to 2029. It is expected to reach above USD 13.6 billion by 2029 from USD 8.57 billion in 2022.
The process of combining, blending, or changing substances to make a treatment specific to the requirements of a particular patient is known as drug compounding. A compounding pharmacy is a type of pharmacy that makes medicines for patients who cannot utilize medications that are sold over the counter. A compounding pharmacy is frequently utilized for patients who have hypoallergenic sensitivities or for extremely young patients who require a modest dosage of a particular drug. Drug compounding is often regarded as the process of combining, mixing, or altering ingredients to create a medication tailored to the needs of an individual patient. Compounding includes the combining of two or more drugs. Compounded drugs are not FDA-approved.
Compounded drugs are frequently utilized to aid improve therapy outcomes by the targeted activities of a particular chemical combination. Additionally, amid national drug shortages, compounded drugs serve as a source of medication. Compounding pharmacy formulates medications according to patient needs and preferences, compounding pharmacy offers precise dosages, which may help to optimize efficacy and minimize side effects it also offers a variety of administration methods. These are some benefits of compounding pharmacies market.
| ATTRIBUTE | DETAILS |
| Study period | 2020-2029 |
| Base year | 2021 |
| Estimated year | 2022 |
| Forecasted year | 2022-2029 |
| Historical period | 2018-2020 |
| Unit | Value (USD BILLION) |
| Segmentation | By Therapeutic Area, By Route of Administration, By Sterility, By Region |
| By Therapeutic Area |
|
| By Route of Administration |
|
| By Sterility |
|
| By Region |
|
In the compound pharmacy method, they can create specially formulated drugs for any patient. Some humans and animals require medicines that aren’t sold on the market. That is drugs that can be obtained at a typical pharmacy but aren’t mass-produced. Compounding pharmacies can help with this demand because there are numerous potential causes for it. Compounding pharmacies can create sterile and non-sterile chemicals. While some pharmacies may provide services for both types of compounding, others may only specialize in one. Injections, ocular drops, and infusions are examples of dosage forms that contain sterile substances. Because of this, if pollutants enter the medication, there is a greater chance of infection or significant issues. To reduce this risk, sterile substances are created in a unique setting with extra specifications. The danger of infection is lower with non-sterile substances. They come as creams, pills, and suppositories in dosing forms.
The size of the worldwide compounding pharmacies market is expected to increase throughout the forecast period as a result of the rise in chronic disease prevalence, population aging, and increased life expectancy. Compounding pharmacies industry trends such as the rising drug failure rate and the severe worldwide drug scarcity also contribute to the compounding pharmacies market size growth. On the other hand, over the projection period for the compounding pharmacies market, the growth potential of emerging economies is anticipated to present lucrative opportunities for the major participant.
The demand for compounded medicines is anticipated to increase in the upcoming years as a result of expanding global drug shortages, rising prices for branded prescription substitutes, and limited access to medications.
Compounding Pharmacies Market Segment Analysis
The global Compounding Pharmacies market is segmented based on Therapeutic Area, Route of Administration, Sterility, and region. By Therapeutic area, the market is bifurcated into Pain Management, Hormone Replacement, Dermal Disorders, Nutritional Supplements, and others. By route of administration, the market is bifurcated into Oral, Topical, and others. By sterility, the market is bifurcated into Sterile compounding drugs and non-sterile compounding drugs.
Based on the Therapeutic area the pain management segment is dominating the Compounding Pharmacies market. Â Due to a growth in the number of geriatric populations, an increase in the number of surgical procedures, and an increase in healthcare spending, the pain management category was the largest contributor to revenue in 2021 and is expected to maintain this trend during the projection period. On the other hand, because of the increase in neurological illnesses and cancer cases, the other segment is anticipated to develop at the highest rate during the projection period.
Based on the route of administration oral segment is dominating in Compounding Pharmacies market. Because there are so many different medications that are designed to be taken orally, the oral category was the largest contributor to revenue in 2021, and it is projected that this trend will continue throughout the forecast period. Since ancient times, the most typical and convenient method of delivering medication has been oral. Oral drugs are readily available in a variety of forms, including granules, powder, tablets, and capsules, making them easy for customers to store and consume.
Based on Sterility non-sterile compounding drug segment is dominating in the Compounding Pharmacies market. Due to the rise in the prevalence of chronic diseases like diabetes, the rising demand for personalized medications, and the rise in the population of elderly people, the non-sterile compounding drugs segment was the largest contributor to revenue in 2021 and is anticipated to maintain this trend during the forecast period.
Compounding Pharmacies Market Players
The Compounding Pharmacies market key players include Advanced Pharmacy, Athenex, B. Braun Melsungen Ag, Dougherty’s Pharmacy Inc, Fresenius Se, and Co. Kgaa, Institutional Pharmacy Solutions, ITC Compounding Pharmacy, New Compounding Pharma, Olympia Pharmacy, Panacea Biomatx Inc, Pencol Compounding Pharmacy, Perrigo Company Plc, Rx Express Compounding Pharmacy, ,3 Compounding Pharmacy, Valor Compounding Pharmacy.
Industry Development:
- In July 2022 Fagron acquired from Fresenius Kabi a 503B outsourcing facility in Boston. Fagron expanded its United States sterile coumpounding footprint.
- In March 2022 Fresenius Kabi acquired major stake in mAbxience which significantly enhances Fresenius Kabi’s presence in high-growth biopharmaceuticals market.
Who Should Buy? Or Key stakeholders
- Healthcare Industries
- Research Organizations
- Government Organizations
- Fitness Industry
- Pharmaceuticals industry
- Others
Compounding Pharmacies Market Regional Analysis
The Compounding Pharmacies market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).
- North America: includes the US, Canada, Mexico
- Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN, and the Rest of APAC
- Europe: includes UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe
- South America: includes Brazil, Argentina, and Rest of South America
- Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA
North America accounted for 35 % share across the global value. The largest market share for compounding pharmacies was held by North America in 2021, and it is projected that this trend would continue throughout the forecast period. Additionally, the region now has a more developed healthcare system, more geriatric patients, and more compounding pharmacies.
The market share of North American compounding pharmacies is divided into sterile and non-sterile segments as well. Due to the increase in chronic pain cases and the consequent demand for non-sterile medications such as pills and topical painkillers, the non-sterile market has seen significant growth. The demand for non-sterile medications including pills, capsules, and syrups is expected to increase, which would help these pharmacies generate more revenue. In 2022, the North American compounding pharmacies market was dominated by the United States, with a market share of approximately 77.4%. Various factors, such as poor skincare habits, unhealthful eating habits, and a family medical history of the ailment, are contributing to an increase in the prevalence of skin problems in North America. There is an alarming increase in the prevalence of acute disorders including dermatitis and melanoma. These are some factors that are helps to propel the market in the North American region.
Key Market Segments: Compounding Pharmacies Market
Compounding Pharmacies Market By Therapeutic Area, 2020-2029, (Usd Billion),
- Pain Management
- Hormone Replacement
- Dermal Disorders
- Nutritional Supplements
- Others
Compounding Pharmacies Market By Route Of Administration, 2020-2029, (Usd Billion)
- Oral
- Topical
- Others
Compounding Pharmacies Market By Sterility, 2020-2029, (Usd Billion)
- Sterile Compounding Drugs
- Non-Sterile Compounding Drugs
Compounding Pharmacies Market By Region, 2020-2029, (Usd Billion)
- North America
- Asia Pacific
- Europe
- South America
- Middle East and Africa
Important Countries in All Regions Are Covered.
Key Question Answered
- What is the current size of the Compounding Pharmacies market?
- What are the key factors influencing the growth of Compounding Pharmacies?
- Who are the major key players in the Compounding Pharmacies market?
- Which region will provide more business opportunities for Compounding Pharmacies in the future?
- Which segment holds the maximum share of the Compounding Pharmacies market?
Table of Content
- Introduction
- Market Definition
- Market Segmentation
- Research Timelines
- Assumptions and Limitations
- Research Methodology
- Data Mining
- Secondary Research
- Primary Research
- Subject-Matter Experts’ Advice
- Quality Checks
- Final Review
- Data Triangulation
- Bottom-Up Approach
- Top-Down Approach
- Research Flow
- Data Sources
- Data Mining
- Executive Summary
- Market Overview
- Global Compounding Pharmacies Market Outlook
- Market Drivers
- Market Restraints
- Market Opportunities
- Impact of Covid-19 On the Compounding Pharmacies Market
- Porter’s five forces model
- Threat from new entrants
- Threat from substitutes
- Bargaining power of suppliers
- Bargaining power of customers
- Degree of competition
- Industry value chain Analysis
- Global Compounding Pharmacies Market Outlook
- Global Compounding Pharmacies Market by Therapeutic Area (USD Billion)
- Pain Management
- Hormone Replacement
- Dermal Disorders
- Nutritional Supplements
- Others
- Global Compounding Pharmacies Market by Route of Administration (USD Billion)
- Oral
- Topical
- Others
- Global Compounding Pharmacies Market by Sterility (USD Billion)
- Sterile Compounding Drugs
- Non-Sterile Compounding Drugs
- Global Compounding Pharmacies Market by Region (USD Billion)
- North America
- US
- Canada
- Mexico
- South America
- Brazil
- Argentina
- Colombia
- Rest Of South America
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest Of Europe
- Asia Pacific
- India
- China
- Japan
- South Korea
- Australia
- South-East Asia
- Rest Of Asia Pacific
- Middle East and Africa
- UAE
- Saudi Arabia
- South Africa
- Rest Of Middle East and Africa
- North America
- Company Profiles*
(Business Overview, Company Snapshot, Products Offered, Recent Developments)
- Advanced Pharmacy
- Athenex
- Braun Melsungen Ag
- Dougherty’s Pharmacy Inc
- Institutional Pharmacy Solutions
- ITC Compounding Pharmacy
- New Compounding Pharma
- Olympia Pharmacy
- Panacea Biomatx Inc
- Pencol Compounding Pharmacy
*The Company List Is Indicative
LIST OF TABLES
TABLE 1Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL COMPOUNDING PHARMACIES MARKET BY TYPE (USD BILLION) 2020-2029
TABLE 2Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL COMPOUNDING PHARMACIES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 3Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL COMPOUNDING PHARMACIES MARKET BY STERILITY (USD BILLION) 2020-2029
TABLE 4Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL COMPOUNDING PHARMACIES MARKET BY ROUTE OF ADMINISTRATION (USD BILLION) 2020-2029
TABLE 5Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL COMPOUNDING PHARMACIES MARKET BY REGION (USD BILLION) 2020-2029
TABLE 6Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA COMPOUNDING PHARMACIES MARKET BY COUNTRY (USD BILLION) 2020-2029
TABLE 7Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA COMPOUNDING PHARMACIES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 8Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA COMPOUNDING PHARMACIES MARKET BY STERILITY (USD BILLION) 2020-2029
TABLE 9Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA COMPOUNDING PHARMACIES MARKET BY ROUTE OF ADMINISTRATION (USD BILLION) 2020-2029
TABLE 10Â Â Â Â Â Â Â Â Â Â Â Â Â US COMPOUNDING PHARMACIES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 11Â Â Â Â Â Â Â Â Â Â Â Â Â US COMPOUNDING PHARMACIES MARKET BY STERILITY (USD BILLION) 2020-2029
TABLE 12Â Â Â Â Â Â Â Â Â Â Â Â Â US COMPOUNDING PHARMACIES MARKET BY ROUTE OF ADMINISTRATION (USD BILLION) 2020-2029
TABLE 13Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA COMPOUNDING PHARMACIES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 14Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA COMPOUNDING PHARMACIES MARKET BY STERILITY (USD BILLION) 2020-2029
TABLE 15Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA COMPOUNDING PHARMACIES MARKET BY ROUTE OF ADMINISTRATION (USD BILLION) 2020-2029
TABLE 16Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO COMPOUNDING PHARMACIES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 17Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO COMPOUNDING PHARMACIES MARKET BY STERILITY (USD BILLION) 2020-2029
TABLE 18Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO COMPOUNDING PHARMACIES MARKET BY ROUTE OF ADMINISTRATION (USD BILLION) 2020-2029
TABLE 19Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA COMPOUNDING PHARMACIES MARKET BY COUNTRY (USD BILLION) 2020-2029
TABLE 20Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA COMPOUNDING PHARMACIES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 21Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA COMPOUNDING PHARMACIES MARKET BY STERILITY (USD BILLION) 2020-2029
TABLE 22Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA COMPOUNDING PHARMACIES MARKET BY ROUTE OF ADMINISTRATION (USD BILLION) 2020-2029
TABLE 23Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL COMPOUNDING PHARMACIES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 24Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL COMPOUNDING PHARMACIES MARKET BY STERILITY (USD BILLION) 2020-2029
TABLE 25Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL COMPOUNDING PHARMACIES MARKET BY ROUTE OF ADMINISTRATION (USD BILLION) 2020-2029
TABLE 26Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA COMPOUNDING PHARMACIES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 27Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA COMPOUNDING PHARMACIES MARKET BY STERILITY (USD BILLION) 2020-2029
TABLE 28Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA COMPOUNDING PHARMACIES MARKET BY ROUTE OF ADMINISTRATION (USD BILLION) 2020-2029
TABLE 29Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA COMPOUNDING PHARMACIES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 30Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA COMPOUNDING PHARMACIES MARKET BY STERILITY (USD BILLION) 2020-2029
TABLE 31Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA COMPOUNDING PHARMACIES MARKET BY ROUTE OF ADMINISTRATION (USD BILLION) 2020-2029
TABLE 32Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA COMPOUNDING PHARMACIES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 33Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA COMPOUNDING PHARMACIES MARKET BY STERILITY (USD BILLION) 2020-2029
TABLE 34Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA COMPOUNDING PHARMACIES MARKET BY ROUTE OF ADMINISTRATION (USD BILLION) 2020-2029
TABLE 35Â Â Â Â Â Â Â Â Â Â Â Â Â ASIA-PACIFIC COMPOUNDING PHARMACIES MARKET BY COUNTRY (USD BILLION) 2020-2029
TABLE 36Â Â Â Â Â Â Â Â Â Â Â Â Â ASIA-PACIFIC COMPOUNDING PHARMACIES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 37Â Â Â Â Â Â Â Â Â Â Â Â Â ASIA-PACIFIC COMPOUNDING PHARMACIES MARKET BY STERILITY (USD BILLION) 2020-2029
TABLE 38Â Â Â Â Â Â Â Â Â Â Â Â Â ASIA-PACIFIC COMPOUNDING PHARMACIES MARKET BY ROUTE OF ADMINISTRATION (USD BILLION) 2020-2029
TABLE 39Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA COMPOUNDING PHARMACIES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 40Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA COMPOUNDING PHARMACIES MARKET BY STERILITY (USD BILLION) 2020-2029
TABLE 41Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA COMPOUNDING PHARMACIES MARKET BY ROUTE OF ADMINISTRATION (USD BILLION) 2020-2029
TABLE 42Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA COMPOUNDING PHARMACIES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 43Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA COMPOUNDING PHARMACIES MARKET BY STERILITY (USD BILLION) 2020-2029
TABLE 44Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA COMPOUNDING PHARMACIES MARKET BY ROUTE OF ADMINISTRATION (USD BILLION) 2020-2029
TABLE 45Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN COMPOUNDING PHARMACIES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 46Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN COMPOUNDING PHARMACIES MARKET BY STERILITY (USD BILLION) 2020-2029
TABLE 47Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN COMPOUNDING PHARMACIES MARKET BY ROUTE OF ADMINISTRATION (USD BILLION) 2020-2029
TABLE 48Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA COMPOUNDING PHARMACIES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 49Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA COMPOUNDING PHARMACIES MARKET BY STERILITY (USD BILLION) 2020-2029
TABLE 50Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA COMPOUNDING PHARMACIES MARKET BY ROUTE OF ADMINISTRATION (USD BILLION) 2020-2029
TABLE 51Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA COMPOUNDING PHARMACIES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 52Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA COMPOUNDING PHARMACIES MARKET BY STERILITY (USD BILLION) 2020-2029
TABLE 53Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA COMPOUNDING PHARMACIES MARKET BY ROUTE OF ADMINISTRATION (USD BILLION) 2020-2029
TABLE 54Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA COMPOUNDING PHARMACIES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 55Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA COMPOUNDING PHARMACIES MARKET BY STERILITY (USD BILLION) 2020-2029
TABLE 56Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA COMPOUNDING PHARMACIES MARKET BY ROUTE OF ADMINISTRATION (USD BILLION) 2020-2029
TABLE 57Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC COMPOUNDING PHARMACIES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 58Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC COMPOUNDING PHARMACIES MARKET BY STERILITY (USD BILLION) 2020-2029
TABLE 59Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC COMPOUNDING PHARMACIES MARKET BY ROUTE OF ADMINISTRATION (USD BILLION) 2020-2029
TABLE 60Â Â Â Â Â Â Â Â Â Â Â Â Â EUROPE COMPOUNDING PHARMACIES MARKET BY COUNTRY (USD BILLION) 2020-2029
TABLE 61Â Â Â Â Â Â Â Â Â Â Â Â Â ASIA-PACIFIC COMPOUNDING PHARMACIES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 62Â Â Â Â Â Â Â Â Â Â Â Â Â ASIA-PACIFIC COMPOUNDING PHARMACIES MARKET BY STERILITY (USD BILLION) 2020-2029
TABLE 63Â Â Â Â Â Â Â Â Â Â Â Â Â ASIA-PACIFIC COMPOUNDING PHARMACIES MARKET BY ROUTE OF ADMINISTRATION (USD BILLION) 2020-2029
TABLE 64Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY COMPOUNDING PHARMACIES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 65Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY COMPOUNDING PHARMACIES MARKET BY STERILITY (USD BILLION) 2020-2029
TABLE 66Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY COMPOUNDING PHARMACIES MARKET BY ROUTE OF ADMINISTRATION (USD BILLION) 2020-2029
TABLE 67Â Â Â Â Â Â Â Â Â Â Â Â Â UK COMPOUNDING PHARMACIES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 68Â Â Â Â Â Â Â Â Â Â Â Â Â UK COMPOUNDING PHARMACIES MARKET BY STERILITY (USD BILLION) 2020-2029
TABLE 69Â Â Â Â Â Â Â Â Â Â Â Â Â UK COMPOUNDING PHARMACIES MARKET BY ROUTE OF ADMINISTRATION (USD BILLION) 2020-2029
TABLE 70Â Â Â Â Â Â Â Â Â Â Â Â Â FRANCE COMPOUNDING PHARMACIES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 71Â Â Â Â Â Â Â Â Â Â Â Â Â FRANCE COMPOUNDING PHARMACIES MARKET BY STERILITY (USD BILLION) 2020-2029
TABLE 72Â Â Â Â Â Â Â Â Â Â Â Â Â FRANCE COMPOUNDING PHARMACIES MARKET BY ROUTE OF ADMINISTRATION (USD BILLION) 2020-2029
TABLE 73Â Â Â Â Â Â Â Â Â Â Â Â Â ITALY COMPOUNDING PHARMACIES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 74Â Â Â Â Â Â Â Â Â Â Â Â Â ITALY COMPOUNDING PHARMACIES MARKET BY STERILITY (USD BILLION) 2020-2029
TABLE 75Â Â Â Â Â Â Â Â Â Â Â Â Â ITALY COMPOUNDING PHARMACIES MARKET BY ROUTE OF ADMINISTRATION (USD BILLION) 2020-2029
TABLE 76Â Â Â Â Â Â Â Â Â Â Â Â Â SPAIN COMPOUNDING PHARMACIES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 77Â Â Â Â Â Â Â Â Â Â Â Â Â SPAIN COMPOUNDING PHARMACIES MARKET BY STERILITY (USD BILLION) 2020-2029
TABLE 78Â Â Â Â Â Â Â Â Â Â Â Â Â SPAIN COMPOUNDING PHARMACIES MARKET BY ROUTE OF ADMINISTRATION (USD BILLION) 2020-2029
TABLE 79Â Â Â Â Â Â Â Â Â Â Â Â Â RUSSIA COMPOUNDING PHARMACIES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 80Â Â Â Â Â Â Â Â Â Â Â Â Â RUSSIA COMPOUNDING PHARMACIES MARKET BY STERILITY (USD BILLION) 2020-2029
TABLE 81Â Â Â Â Â Â Â Â Â Â Â Â Â RUSSIA COMPOUNDING PHARMACIES MARKET BY ROUTE OF ADMINISTRATION (USD BILLION) 2020-2029
TABLE 82Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE COMPOUNDING PHARMACIES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 83Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE COMPOUNDING PHARMACIES MARKET BY STERILITY (USD BILLION) 2020-2029
TABLE 84Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE COMPOUNDING PHARMACIES MARKET BY ROUTE OF ADMINISTRATION (USD BILLION) 2020-2029
TABLE 85Â Â Â Â Â Â Â Â Â Â Â Â Â MIDDLE EAST AND AFRICA COMPOUNDING PHARMACIES MARKET BY COUNTRY (USD BILLION) 2020-2029
TABLE 86Â Â Â Â Â Â Â Â Â Â Â Â Â MIDDLE EAST AND AFRICA COMPOUNDING PHARMACIES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 87Â Â Â Â Â Â Â Â Â Â Â Â Â MIDDLE EAST AND AFRICA COMPOUNDING PHARMACIES MARKET BY STERILITY (USD BILLION) 2020-2029
TABLE 88Â Â Â Â Â Â Â Â Â Â Â Â Â MIDDLE EAST AND AFRICA COMPOUNDING PHARMACIES MARKET BY ROUTE OF ADMINISTRATION (USD BILLION) 2020-2029
TABLE 89Â Â Â Â Â Â Â Â Â Â Â Â Â UAE COMPOUNDING PHARMACIES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 90Â Â Â Â Â Â Â Â Â Â Â Â Â UAE COMPOUNDING PHARMACIES MARKET BY STERILITY (USD BILLION) 2020-2029
TABLE 91Â Â Â Â Â Â Â Â Â Â Â Â Â UAE COMPOUNDING PHARMACIES MARKET BY ROUTE OF ADMINISTRATION (USD BILLION) 2020-2029
TABLE 92Â Â Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA COMPOUNDING PHARMACIES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 93Â Â Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA COMPOUNDING PHARMACIES MARKET BY STERILITY (USD BILLION) 2020-2029
TABLE 94Â Â Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA COMPOUNDING PHARMACIES MARKET BY ROUTE OF ADMINISTRATION (USD BILLION) 2020-2029
TABLE 95Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA COMPOUNDING PHARMACIES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 96Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA COMPOUNDING PHARMACIES MARKET BY STERILITY (USD BILLION) 2020-2029
TABLE 97Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA COMPOUNDING PHARMACIES MARKET BY ROUTE OF ADMINISTRATION (USD BILLION) 2020-2029
TABLE 98Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA COMPOUNDING PHARMACIES MARKET BY THERAPEUTIC AREA (USD BILLION) 2020-2029
TABLE 99Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA COMPOUNDING PHARMACIES MARKET BY STERILITY (USD BILLION) 2020-2029
TABLE 100Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA COMPOUNDING PHARMACIES MARKET BY ROUTE OF ADMINISTRATION (USD BILLION) 2020-2029
LIST OF FIGURES
FIGURE 1Â Â Â Â Â Â Â MARKET DYNAMICS
FIGURE 2Â Â Â Â Â Â Â MARKET SEGMENTATION
FIGURE 3Â Â Â Â Â Â Â REPORT TIMELINES: YEARS CONSIDERED
FIGURE 4Â Â Â Â Â Â Â DATA TRIANGULATION
FIGURE 5Â Â Â Â Â Â Â BOTTOM-UP APPROACH
FIGURE 6Â Â Â Â Â Â Â TOP-DOWN APPROACH
FIGURE 7Â Â Â Â Â Â Â RESEARCH FLOW
FIGURE 8Â Â Â Â Â Â Â GLOBAL COMPOUNDING PHARMACIES MARKET BY THERAPEUTIC AREA, USD BILLION, 2020-2029
FIGURE 9Â Â Â Â Â Â Â GLOBAL COMPOUNDING PHARMACIES MARKET BY ROUTE OF ADMINISTRATION, USD BILLION, 2020-2029
FIGURE 10Â Â Â Â Â GLOBAL COMPOUNDING PHARMACIES MARKET BY STERILITY, USD BILLION, 2020-2029
FIGURE 11Â Â Â Â Â GLOBAL COMPOUNDING PHARMACIES MARKET BY REGION, USD BILLION, 2020-2029
FIGURE 12          PORTER’S FIVE FORCES MODEL
FIGURE 13Â Â Â Â Â GLOBAL COMPOUNDING PHARMACIES MARKET BY THERAPEUTIC AREA, USD BILLION, 2021
FIGURE 14Â Â Â Â GLOBAL COMPOUNDING PHARMACIES MARKET BY ROUTE OF ADMINISTRATION, USD Â Â Â Â Â Â Â Â Â Â Â Â Â BILLION, 2021
FIGURE 15Â Â Â Â Â GLOBAL COMPOUNDING PHARMACIES MARKET BY STERILITY, USD BILLION, 2021
FIGURE 16Â Â Â Â Â GLOBAL COMPOUNDING PHARMACIES MARKET BY REGION, USD BILLION, 2021
FIGURE 13Â Â Â Â Â Â Â Â Â Â NORTH AMERICA COMPOUNDING PHARMACIES MARKET SNAPSHOT
FIGURE 14Â Â Â Â Â Â Â Â Â Â EUROPE COMPOUNDING PHARMACIES MARKET SNAPSHOT
FIGURE 15Â Â Â Â Â Â Â Â Â Â ASIA PACIFIC COMPOUNDING PHARMACIES MARKET SNAPSHOT
FIGURE 16Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA COMPOUNDING PHARMACIES MARKET SNAPSHOT
FIGURE 17Â Â Â Â Â Â Â Â Â Â MIDDLE EAST & AFRICA COMPOUNDING PHARMACIES MARKET SNAPSHOT
FIGURE 18Â Â Â Â Â Â Â Â Â Â MARKET SHARE ANALYSIS
FIGURE 19Â Â Â Â Â Â Â Â Â Â ADVANCED PHARMACY: COMPANY SNAPSHOT
FIGURE 20Â Â Â Â Â Â Â Â Â Â ATHENEX: COMPANY SNAPSHOT
FIGURE 21Â Â Â Â Â Â Â Â Â Â B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
FIGURE 22Â Â Â Â Â Â Â Â Â Â DOUGHERTY’S PHARMACY INC: COMPANY SNAPSHOT
FIGURE 23Â Â Â Â Â Â Â Â Â Â INSTITUTIONAL PHARMACY SOLUTIONS: COMPANY SNAPSHOT
FIGURE 24Â Â Â Â Â Â Â Â Â Â ITC COMPOUNDING PHARMACY: COMPANY SNAPSHOT
FIGURE 25Â Â Â Â Â Â Â Â Â Â VALOR COMPOUNDING PHARMACY: COMPANY SNAPSHOT
FIGURE 26Â Â Â Â Â Â Â Â Â Â OLYMPIA PHARMACY: COMPANY SNAPSHOT
FIGURE 27Â Â Â Â Â Â Â Â Â Â PANACEA BIOMATX INC: COMPANY SNAPSHOT
FAQ
The global Compounding Pharmacies market is expected to grow at 6.8 % CAGR from 2020 to 2029. It is expected to reach above USD 13.6 billion by 2029 from USD 8.57 billion in 2022.
The pain management segment is the most influencing segment owing to the increase in the number of geriatric populations, rise in the number of surgical procedures, and rise in healthcare expenditure.
The market value of the Compounding Pharmacies Market in 2029 is USD 12.1 Billion.
The forecast period for the Compounding Pharmacies Market is 2022 to 2029
In-Depth Database
Our Report’s database covers almost all topics of all regions over the Globe.
Recognised Publishing Sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales
support.
Safe & Secure
Complete secure payment
process.